Find Out if You Qualify for a Financial Reward by filling out the form below.
Investigation Details
On Dec. 5, 2023, hedge fund Viceroy released a second research report on Arbor after purportedly receiving information from “whistleblowers” regarding distressed Arbor deals and underlying assets.
Viceroy’s report, entitled “Arbor – Jacksonville Case Study”, highlights three multifamily properties in the Jacksonville, Florida area encumbered by Arbor loans, which the hedge fund submits have property values likely below Arbor’s loan balances.
The hedge fund states, “Viceroy’s dive into Arbor’s CLOs suggests its entire loan book is distressed and underlying collateral is vastly overstated. These loans do not qualify for refinancing anywhere, and substantially all mature within the next 18 months.” Viceroy concludes, “We believe Arbor is a donut. $0.00.”
Ticker Symbol | Company Name | Join Deadline | Join |
---|---|---|---|
APLT | Applied Therapeutics, Inc. | February 18, 2025 | Join |
BIOA | BioAge Labs, Inc. | March 10, 2025 | Join |
PCRX | Pacira BioSciences, Inc. | March 14, 2025 | Join |
NVO | Novo Nordisk A/S | March 25, 2025 | Join |
GO | Grocery Outlet Holding Corp. | March 31, 2025 | Join |
NEM | Newmont Corporation | April 01, 2025 | Join |
GSK | GSK plc | April 07, 2025 | Join |
NTLA | Intellia Therapeutics, Inc. | April 14, 2025 | Join |
MRK | Merck & Co., Inc. | April 14, 2025 | Join |